Medicare should be allowed to negotiate with Big Pharma to lower the cost of prescription drugs, Republican presidential front-runner Donald Trump told supporters in New Hampshire Monday night.
Such a policy — long opposed by Republicans and backed by Democrats — would save billions of dollars, the Republican presidential front-runner said, noting that pressure from the leading pharmaceuticals has prevented it.
"We don't do it. Why? Because of the drug companies," Trump told the crowd during an appearance in Farmington.
Medicare is prohibited from negotiating drug prices under the 2003 Medicare prescription drug law.
reports the proposal comes as high drug prices are under tighter scrutiny with a bipartisan investigation by the Senate Aging Committee underway.
In addition, the House Oversight Committee has former drug company CEO Martin Shkreli — who jacked up the HIV-fighting drug Daraprim by 5,556 percent, from $13.50 to $750 per dose — scheduled to testify next month.
Democratic presidential front-runner Hillary Clinton and her chief rival Sen. Bernie Sanders have also called for a policy that would allow prices to be negotiated.
© 2022 Newsmax. All rights reserved.